Does Rallies show 13F holders for BCYC?

Yes. Rallies tracks hedge fund and 13F ownership data for BCYC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BCYC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BCYC. It does not provide personalized investment advice.

BCYC (Bicycle Therapeutics plc American Depositary Shares) Stock Analysis - Hedge Fund Holdings

Bicycle Therapeutics plc American Depositary Shares (BCYC) is a publicly traded Healthcare sector company. As of May 21, 2026, BCYC trades at $4.47 with a market cap of $304.38M and a P/E ratio of -1.22. BCYC moved +1.72% today. Year to date, BCYC is -33.13%; over the trailing twelve months it is -48.06%. Its 52-week range spans $4.24 to $28.67. Analyst consensus is buy with an average price target of $13.57. Rallies surfaces BCYC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BCYC stock?

Hedge funds tracked by Rallies that own BCYC include Duquesne Family. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bicycle Therapeutics plc American Depositary Shares.

BCYC Key Metrics

Key financial metrics for BCYC
Metric	Value
Price	$4.47
Market Cap	$304.38M
P/E Ratio	-1.22
EPS	$-3.62
Dividend Yield	0.00%
52-Week High	$28.67
52-Week Low	$4.24
Volume	7
Avg Volume	0
Revenue (TTM)	$28.34M
Net Income	$-250.66M
Gross Margin	0.00%

Top Hedge Funds Holding BCYC

Duquesne Family holds 190.20K shares of BCYC, changed +0.00% as of Sep 30, 2024.

Latest BCYC News

Bicycle Therapeutics Depioritizes Zelenectide, Cuts Costs 50% and Extends Runway to 2030 — Mar 17, 2026

Recent BCYC Insider Trades

Hannay Michael Charles Ferguson sold 251 (~$1.27K) on Apr 6, 2026.
Thompson Travis Alvin sold 102 (~$515.1) on Apr 6, 2026.
Perry Jennifer Scott sold 37 (~$186.85) on Apr 6, 2026.

BCYC Analyst Consensus

8 analysts cover BCYC: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.57.

Common questions about BCYC

Who owns BCYC stock?: Hedge funds tracked by Rallies that own BCYC include Duquesne Family. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bicycle Therapeutics plc American Depositary Shares.
Does Rallies show 13F holders for BCYC?: Yes. Rallies tracks hedge fund and 13F ownership data for BCYC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BCYC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BCYC. It does not provide personalized investment advice.